FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Preferred Pharmaceuticals Inc Recall

Preferred Pharmaceuticals Inc

Preferred Pharmaceuticals, Inc. · Anaheim, CA

Risk level
Class II
Reported by FDA
May 26, 2021
Recall ID
D-0385-2021
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Preferred Pharmaceuticals Inc starting Apr 28, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0385-2021 on May 26, 2021. Reason: CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day. Status: Ongoing.

Why it was recalled

CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.

Product description

Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1

Lot numbers, UPCs & expiration codes

Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022

Where it was sold

Distributed to two physician consignees located in FL.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0385-2021
Classification
Class II
Status
Ongoing
Recall initiated
Apr 28, 2021
FDA report date
May 26, 2021
Quantity
147 bottles (14,700 extended release tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0385-2021, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Ongoing
Country
United States
Event ID
87833
Address
1250 N Lakeview Ave Ste O
Code information
Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022
Postal code
92807-1801
Report date
May 26, 2021
Product type
Drugs
Recall number
D-0385-2021
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc.
Product quantity
147 bottles (14,700 extended release tablets)
Reason for recall
CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1
Distribution pattern
Distributed to two physician consignees located in FL.
Recall initiation date
Apr 28, 2021
Center classification date
May 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0385-2021, published May 26, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls